These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19104017)

  • 21. The Emergence of Reduced Ciprofloxacin Susceptibility in Salmonella enterica Causing Bloodstream Infections in Rural Ghana.
    Eibach D; Al-Emran HM; Dekker DM; Krumkamp R; Adu-Sarkodie Y; Cruz Espinoza LM; Ehmen C; Boahen K; Heisig P; Im J; Jaeger A; von Kalckreuth V; Pak GD; Panzner U; Park SE; Reinhardt A; Sarpong N; Schütt-Gerowitt H; Wierzba TF; Marks F; May J
    Clin Infect Dis; 2016 Mar; 62 Suppl 1():S32-6. PubMed ID: 26933017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.
    Vinué L; Corcoran MA; Hooper DC; Jacoby GA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1537-45. PubMed ID: 26711751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the Fluoroquinolone Antibiotic Resistance Mechanism of Salmonella enterica Isolates.
    Kim SY; Lee SK; Park MS; Na HT
    J Microbiol Biotechnol; 2016 Sep; 26(9):1605-12. PubMed ID: 27116992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and Physiological Characterization of Fluoroquinolone-Highly Resistant
    Vidovic S; An R; Rendahl A
    Front Microbiol; 2019; 10():729. PubMed ID: 31024504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinolone Resistance Determinants of Clinical Salmonella Enteritidis in Thailand.
    Utrarachkij F; Nakajima C; Changkwanyeun R; Siripanichgon K; Kongsoi S; Pornruangwong S; Changkaew K; Tsunoda R; Tamura Y; Suthienkul O; Suzuki Y
    Microb Drug Resist; 2017 Oct; 23(7):885-894. PubMed ID: 28437229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Salmonella Isolates from Chicken and Pig Slaughterhouses and Emergence of Ciprofloxacin and Cefotaxime Co-Resistant S. enterica Serovar Indiana in Henan, China.
    Bai L; Lan R; Zhang X; Cui S; Xu J; Guo Y; Li F; Zhang D
    PLoS One; 2015; 10(12):e0144532. PubMed ID: 26650239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
    Levy DD; Sharma B; Cebula TA
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2355-63. PubMed ID: 15215081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro Development of Ciprofloxacin Resistance of Salmonella enterica Serovars Typhimurium, Enteritidis, and Indiana Isolates from Food Animals.
    Zhang WH; Zhang CZ; Liu ZJ; Gu XX; Li W; Yang L; Liu YH; Zeng ZL; Jiang HX
    Microb Drug Resist; 2017 Sep; 23(6):687-694. PubMed ID: 28085562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of acrB and ramA in fluoroquinolone resistant mutants from multi-drug resistant Salmonella enterica serovar Haardt.
    Kim KY; Woo GJ
    Lett Appl Microbiol; 2011 May; 52(5):484-90. PubMed ID: 21299579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
    Cavaco LM; Frimodt-Møller N; Hasman H; Guardabassi L; Nielsen L; Aarestrup FM
    Microb Drug Resist; 2008 Jun; 14(2):163-9. PubMed ID: 18500921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteine auxotrophy drives reduced susceptibility to quinolones and paraquat by inducing the expression of efflux-pump systems and detoxifying enzymes in S. Typhimurium.
    Villagra NA; Valenzuela LM; Mora AY; Millanao AR; Saavedra CP; Mora GC; Hidalgo AA
    Biochem Biophys Res Commun; 2019 Jul; 515(2):339-344. PubMed ID: 31151825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential gene expression by RamA in ciprofloxacin-resistant Salmonella Typhimurium.
    Zheng J; Tian F; Cui S; Song J; Zhao S; Brown EW; Meng J
    PLoS One; 2011; 6(7):e22161. PubMed ID: 21811569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of quinolone-resistance acquisition on biofilm production and fitness in Salmonella enterica.
    Fàbrega A; Soto SM; Ballesté-Delpierre C; Fernández-Orth D; Jiménez de Anta MT; Vila J
    J Antimicrob Chemother; 2014 Jul; 69(7):1815-24. PubMed ID: 24706735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase of multidrug efflux pump expression in fluoroquinolone-resistant Salmonella mutants induced by ciprofloxacin selective pressure.
    Kang HW; Woo GJ
    Res Vet Sci; 2014 Oct; 97(2):182-6. PubMed ID: 25128419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarR.
    Linde HJ; Notka F; Metz M; Kochanowski B; Heisig P; Lehn N
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1865-8. PubMed ID: 10858345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica.
    Randall LP; Cooles SW; Piddock LJ; Woodward MJ
    J Antimicrob Chemother; 2004 Sep; 54(3):688-91. PubMed ID: 15243029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular study of quinolone resistance mechanisms and clonal relationship of Salmonella enterica clinical isolates.
    Ballesté-Delpierre C; Solé M; Domènech Ò; Borrell J; Vila J; Fàbrega A
    Int J Antimicrob Agents; 2014 Feb; 43(2):121-5. PubMed ID: 24139882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
    Chen S; Cui S; McDermott PF; Zhao S; White DG; Paulsen I; Meng J
    Antimicrob Agents Chemother; 2007 Feb; 51(2):535-42. PubMed ID: 17043131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003.
    Marimón JM; Gomáriz M; Zigorraga C; Cilla G; Pérez-Trallero E
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3789-93. PubMed ID: 15388435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.